CCR4-NOT Complex Regulates Gene Expression and Cellular Processes

CCR4-NOT Complex Regulates Gene Expression and Cellular Processes

The CCR4-NOT transcription complex is a protein complex that plays a crucial role in the regulation of gene expression in the cell. The complex is composed of the transcription factor CRISPR-Cas9, the RNA polymerase II (RNA-II), and the protein NOT. The CCR4-NOT complex is a well-established player in the regulation of gene expression and has been implicated in a wide range of cellular processes, including cell growth, differentiation, and the response to external stimuli.

The CCR4-NOT complex was first identified through biochemical studies using cell culture assays and RNA sequencing. The complex was found to consist of a specific combination of protein subunits, including CRISPR-Cas9, NOT1, NOT2, and NOT3. These subunits form a stable complex that is able to recruit RNA-II to target gene loci for transcription.

The NOT protein is a key component of the CCR4-NOT complex and is responsible for the regulation of gene expression. NOT1 and NOT2 are known as the N-terminal subunits, while NOT3 is the C-terminal subunit. All three subunits contain a N -terminal alpha-helix and a C-terminal domain that is involved in interactions with other proteins. The NOT protein is known to have a number of different functions, including the regulation of DNA binding, the repression of gene expression, and the regulation of cellular processes such as cell division and the response to stress.

One of the key functions of the CCR4-NOT complex is the regulation of gene expression. The complex is able to recruit RNA-II to specific gene loci and then regulate the activity of RNA-II to ensure that only the desired genes are expressed. This is accomplished through a process called \"Not-dependent recruitment,\" which allows the CCR4-NOT complex to specifically target gene loci for transcription.

The CCR4-NOT complex is also involved in the regulation of cellular processes such as cell growth and the response to external stimuli. For example, when cells are exposed to UV radiation, the NOT protein is activated and the CCR4-NOT complex is able to recruit RNA-II to the UV-sensitive gene loci to ensure that these genes are transcribed and translated into proteins that are able to repair damaged DNA.

In addition to its role in gene expression regulation, the CCR4-NOT complex is also a potential drug target or biomarker. The NOT protein has been shown to be involved in a wide range of cellular processes, including the regulation of cell growth, the response to external stimuli, and the regulation of the cell cycle. Therefore, targeting the NOT protein with small molecules or other therapeutic agents may be a promising strategy for the development of new treatments for a wide range of diseases.

In conclusion, the CCR4-NOT transcription complex is a complex protein that plays a crucial role in the regulation of gene expression in the cell. The complex is composed of the transcription factor CRISPR-Cas9, the RNA polymerase II, and the protein NOT. The NOT protein is involved in the regulation of gene expression, the regulation of cellular processes such as cell growth and the response to external stimuli, and may be a potential drug target or biomarker. Further research is needed to fully understand the role of the CCR4 -NOT complex in cellular processes and its potential as a therapeutic target.

Protein Name: CCR4-NOT Transcription Complex

The "CCR4-NOT transcription complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCR4-NOT transcription complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CCR5 | CCR5AS | CCR6 | CCR7 | CCR8 | CCR9 | CCRL2 | CCS | CCSAP | CCSER1 | CCSER2 | CCT2 | CCT3 | CCT4 | CCT5 | CCT6A | CCT6B | CCT6P1 | CCT6P3 | CCT7 | CCT8 | CCT8L1P | CCT8L2 | CCT8P1 | CCZ1 | CCZ1B | CCZ1P-OR7E38P | CD101 | CD101-AS1 | CD109 | CD14 | CD151 | CD160 | CD163 | CD163L1 | CD164 | CD164L2 | CD177 | CD177P1 | CD180 | CD19 | CD1A | CD1B | CD1C | CD1D | CD1E | CD2 | CD200 | CD200R1 | CD200R1L | CD207 | CD209 | CD22 | CD226 | CD24 | CD244 | CD247 | CD248 | CD24P2 | CD27 | CD27-AS1 | CD274 | CD276 | CD28 | CD2AP | CD2BP2 | CD3 Complex (T Cell Receptor Complex) | CD300A | CD300C | CD300E | CD300LB | CD300LD | CD300LD-AS1 | CD300LF | CD300LG | CD302 | CD320 | CD33 | CD34 | CD36 | CD37 | CD38 | CD3D | CD3E | CD3G | CD4 | CD40 | CD40LG | CD44 | CD44-DT | CD46 | CD47 | CD48 | CD5 | CD52 | CD53 | CD55 | CD58 | CD59 | CD5L